Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Genetic Disease Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genetic Disease Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetic Disease Diagnosis Overall Market Size
2.1 Global Genetic Disease Diagnosis Market Size: 2022 VS 2028
2.2 Global Genetic Disease Diagnosis Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Genetic Disease Diagnosis Players in Global Market
3.2 Global Companies Genetic Disease Diagnosis Product & Technology
4 Players Profiles
4.1 Abbott Laboratories
4.1.1 Abbott Laboratories Corporate Summary
4.1.2 Abbott Laboratories Business Overview
4.1.3 Abbott Laboratories Genetic Disease Diagnosis Product Offerings & Technology
4.1.4 Abbott Laboratories Genetic Disease Diagnosis R&D, and Plans
4.2 Siemens Healthineers
4.2.1 Siemens Healthineers Corporate Summary
4.2.2 Siemens Healthineers Business Overview
4.2.3 Siemens Healthineers Genetic Disease Diagnosis Product Offerings & Technology
4.2.4 Siemens Healthineers Genetic Disease Diagnosis R&D, and Plans
4.3 Roche Diagnostics Corp
4.3.1 Roche Diagnostics Corp Corporate Summary
4.3.2 Roche Diagnostics Corp Business Overview
4.3.3 Roche Diagnostics Corp Genetic Disease Diagnosis Product Offerings & Technology
4.3.4 Roche Diagnostics Corp Genetic Disease Diagnosis R&D, and Plans
4.4 Bayer Diagnostics
4.4.1 Bayer Diagnostics Corporate Summary
4.4.2 Bayer Diagnostics Business Overview
4.4.3 Bayer Diagnostics Genetic Disease Diagnosis Product Offerings & Technology
4.4.4 Bayer Diagnostics Genetic Disease Diagnosis R&D, and Plans
4.5 Sysmex Corporation
4.5.1 Sysmex Corporation Corporate Summary
4.5.2 Sysmex Corporation Business Overview
4.5.3 Sysmex Corporation Genetic Disease Diagnosis Product Offerings & Technology
4.5.4 Sysmex Corporation Genetic Disease Diagnosis R&D, and Plans
4.6 Cephide
4.6.1 Cephide Corporate Summary
4.6.2 Cephide Business Overview
4.6.3 Cephide Genetic Disease Diagnosis Product Offerings & Technology
4.6.4 Cephide Genetic Disease Diagnosis R&D, and Plans
4.7 Bio-Rad Laboratories
4.7.1 Bio-Rad Laboratories Corporate Summary
4.7.2 Bio-Rad Laboratories Business Overview
4.7.3 Bio-Rad Laboratories Genetic Disease Diagnosis Product Offerings & Technology
4.7.4 Bio-Rad Laboratories Genetic Disease Diagnosis R&D, and Plans
4.8 Thermo Fisher Scientific
4.8.1 Thermo Fisher Scientific Corporate Summary
4.8.2 Thermo Fisher Scientific Business Overview
4.8.3 Thermo Fisher Scientific Genetic Disease Diagnosis Product Offerings & Technology
4.8.4 Thermo Fisher Scientific Genetic Disease Diagnosis R&D, and Plans
4.9 Illumina, Inc
4.9.1 Illumina, Inc Corporate Summary
4.9.2 Illumina, Inc Business Overview
4.9.3 Illumina, Inc Genetic Disease Diagnosis Product Offerings & Technology
4.9.4 Illumina, Inc Genetic Disease Diagnosis R&D, and Plans
4.10 Applied Biosystems
4.10.1 Applied Biosystems Corporate Summary
4.10.2 Applied Biosystems Business Overview
4.10.3 Applied Biosystems Genetic Disease Diagnosis Product Offerings & Technology
4.10.4 Applied Biosystems Genetic Disease Diagnosis R&D, and Plans
4.11 Transgenomic Inc
4.11.1 Transgenomic Inc Corporate Summary
4.11.2 Transgenomic Inc Business Overview
4.11.3 Transgenomic Inc Genetic Disease Diagnosis Product Offerings & Technology
4.11.4 Transgenomic Inc Genetic Disease Diagnosis R&D, and Plans
4.12 AutoGenomics
4.12.1 AutoGenomics Corporate Summary
4.12.2 AutoGenomics Business Overview
4.12.3 AutoGenomics Genetic Disease Diagnosis Product Offerings & Technology
4.12.4 AutoGenomics Genetic Disease Diagnosis R&D, and Plans
5 Sights by Region
5.1 By Region - Global Genetic Disease Diagnosis Market Size, 2023 & 2028
5.2 By Region - Global Genetic Disease Diagnosis Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of Genetic Disease Diagnosis in United States
5.3.2 United States Genetic Disease Diagnosis Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Genetic Disease Diagnosis in Europe
5.4.2 Europe Genetic Disease Diagnosis Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Genetic Disease Diagnosis in China
5.5.2 China Genetic Disease Diagnosis Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global Genetic Disease Diagnosis Market Size Markets, 2023 & 2028
6.2 Robotic Radiosurgery
6.3 Usage Of Molecular Target Agents
6.4 Others
7 Sights by Application
7.1 By Application - Global Genetic Disease Diagnosis Market Size, 2023 & 2028
7.2 Inherited Disorder Testing
7.3 Pharmacogenetic Testing (PGx)
7.4 Human Leukocyte Antigen (HLA) Testing
7.5 Oncology Testing
7.6 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer